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in close proximity and together constitute the major binding 
Abstract Interleukin-8 (IL-8) is implicated in the pathogenesis domain for IL-8 [11]. We have demonstrated that thiol residues 
of a large number of neutrophil-driven inflammatory diseases, of the IL-8R participate in the ligand binding and their chemi- 
Although the cytokine activates neutrophils through a receptor, cal modification impairs IL-8 mediated functions in neutrophils 
no information is available regarding the regulation of IL-8 recep- 
tor (IL-8R) expression. The present study shows that, compared [12,13]. 
to control, the bacterial products - formylpeptide and LPS Although IL-8 has been implicated in the pathogenesis of a 
(serum-activated) upregulate IL-8 receptor by 54% and 115%, large number of neutrophil driven inflammatory diseases and 
respectively, the former by degranulation of the secretory vesicle its receptors play a crucial role in the IL-8 mediated functions, 
and the latter by de novo protein synthesis. The newly expressed knowledge about he regulation of IL-8 receptor expression on 
IL-8R could be demonstrated with anti-IL-8R-antibody and by the surface of target cells is meagre and needs investigation i
autoradiogram of the receptor crosslinked with [lzsI]IL-8. The detail. The bacterial product - tMLP is a potent stimulator of 
study may be useful for understanding the potential role of IL-8 phagocytic cells causing respiratory burst response and release 
during neutrophil mediated inflammatory response, of lysosomal enzymes [14]. The LPS is also a potent stimulant 
Key words'." Interleukin-8; IL-8 receptor; Lipopolysaccharide; which triggers cellular, physiological nd metabolic activities of 
fMLP; Inflammation the host [15]. In this communication wepresent evidences that 
fMLP and LPS upregulate the IL-8R in human neutrophils. 
2. Materials and methods 
1. Introduction 
Human recombinant IL-8 (2 × 107 U/mg) was a gift from Prof. K. 
Polymorphonuclear neutrophils (PMNS), the wandering Matsushima, Kanazawa University, Japan and from Dainippon Phar- 
phagocytic white blood cells provide a first line defense in host maceutical Co., Osaka, Japan. E. coli LPS (055 : B5), N-formyl- 
methionyMeucyl-phenylalanine, cycloheximide, actinomycin D, col- 
against bacterial and fungal infections. During bacterial infec- chicine, chloramine-T, polymixin B sulfate, calcium ionophore 
tion, lipopolysaccharides, derived from the cell wall of Gram- (A23187), anti-human CD14 MOAb (UCHM-1), anti-rabbit IgG anti- 
negative bacteria stimulate the synthesis and secretion of inter- body (raised in goat) were purchased from Sigma Chemical Co., St. 
leukins in a number of cells. One such stimulatory effect of LPS Louis, MO, USA. Ficoll-paque, Sephadex G-10 and Dextran T-500 
in monocytes i the secretion of Interleukin-8 which can che- were obtained from Pharmacia Fine Chemicals, Upsala, Sweden. Other 
chemicals and reagents were of analytical grade. Polyclonal human 
moattract polymorphonuclear neutrophils in vitro and in vivo anti-IL-8R antibody was raised in rabbits against 58 kDa receptor 
[1-3]. Recently, IL-8 has been implicated in the pathogenesis protein of human eutrophils and the anti-IL-8R antibody was charac- 
of a large number of neutrophil driven inflammatory diseases terized by 60-70% binding inhibition of [125I]IL-8 to neutrophils and 
like joint diseases, lung diseases and skin diseases [2-4]. The also by Western blotting analysis. 
Human neutrophils were separated from fresh peripheral venous 
cytokine activates neutrophil and augments inflammatory e- blood of healthy donors by dextran sedimentation followed by Ficoll- 
sponses by inducing release of free toxic oxygen radicals and paque centrifugation method [16]. The preparation contained 90-95% 
proteolytic enzymes [3,4]. The function of IL-8 is mediated PMNs. By Trypan blue dye exclusion method the viability of prepared 
through areceptor expressed on the surface ofneutrophils [5,6]. neutrophils were examined and about 98% cells were viable. 
Human recombinant IL-8 and anti-rabbit IgG antibody were radio- 
Two types of the glycosylated IL-8 receptors, termed A and B, labelled with ~2sI by chloramine-T following the method of Grob et al. 
are known to be expressed in the same mammalian cell types [17]. The specific activity of labelled IL-8 was 3 x 107 to 5 x 107 cpm//2g 
[7,8]. At 37°C, the receptors are rapidly downregulated with its protein. The biological activity of IL-8 and IL-8-induced migration of 
own ligand IL-8 and then the internalised receptors are recycled neutrophils were examined ina modified Boyden chemotactic chamber 
back to cell surface to accept fresh ligands. Continuous recy- (Neuroprobe Inc., Bethesda, MD), using polyvinyl pyrrolidone free 
polycarbonate filter (10/tm thick, 3/2m pore size) [9,12]. 
cling of the receptors is linked to the IL-8 induced migration The chemical crosslinking was carried out following the method of 
of neutrophils [9]. The receptor belongs to the superfamily of Dower [18]. Human eutrophils were incubated with [~zsI]IL-8 at 4°C. 
seven transmembrane domain containing proteins that bind to After washing with cold D-PBS the cells were suspended in 100/A 
G-protein [4,10]. Recently, it has been reported that, the N- D-PBS. Then DSS (1 mg/ml) was added with gentle stirring and incu- 
terminal region and the extracellular loop-3 of the receptor lie bated at 4°C for 1 h. After washing the cells, 100/.tl CHAPS (9 mM) 
in D-PBS and a cocktail of protease inhibitors containing PMSF (200 
/2M), leupeptin (1 /.tM), pepstatin (1/2M) and EDTA (100/2M) were 
added and kept for 10 min in ice. After mixing thoroughly, centrifuga- 
tion was carried out at 4°C for 15 min at 10,000 rpm. The supernatant 
was analysed in SDS-PAGE (10%) under educing condition. The gel 
was dried and autoradiography was carried out using Kodak X-Omat- 
*Corresponding author. K film at -70°C. 
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3. Results were ineffective in blocking LPS mediated stimulation but as 
in the case of fMLP induced stimulation, 90% of IL-8 binding 
3.1. Effect offormyl peptide and alkaline phosphatase r lease were inhibited by colchicine 
Our primary interest was to examine whether fMLP had any (50 aM). The results were opposite during SA-LPS mediated 
effect on the IL-8 receptor level in PMNs. For that purpose, stimulation where colchicine was ineffective in reducing IL-8 
we incubated human PMNs for 30 rain at 37°C with different binding, and no significant release of alkaline phosphatase was 
amounts of fMLP and after washing, the binding of [~25I]IL-8 detected. But the IL-8 binding was strongly inhibited by both 
to PMNs was measured. As can be seen in Fig. 1, IL-8 binding actinomycin D (1 aM) and cycloheximide (10/tg/ml). Under 
to PMNs was increased upto 1/IM fMLP in a dose dependent identical conditions, incubation of control cells with the meta- 
manner which was reduced upon further addition of fMLP. An bolic blockers did not show any alteration of IL-8 binding. 
optimum dose of fMLP (1 HM) could elicit a maximum of 54% 
increase (P < 0.001) in the binding of IL-8 to PMNs with re- 3.5. Effect ofpolymixin B and anti-CD14 antibody 
spect to control (Fig. 1). Poymixin B is known to interact with LPS and may neutral- 
ize the effect of LPS. To examine this, polymixin B (50/lg/ml) 
3.2. Source oflL-8R was added during incubation of LPS with serum at 37°C and 
To find out the source of IL-8R two metabolic blockers - with this LPS no significant increase in binding of the IL-8 to 
actinomycin D (1 /.zM) and cycloheximide (10/lg/ml) were PMN surface was observed. A receptor for LPS, CD14, is 
preincubated with PMN separately before addition of fMLP. moderately expressed on the surface of PMNs and may partic- 
Neither of the compounds had any significant effect on IL-8 ipate during SA-LPS mediated stimulation. In order to investi- 
binding. Treatment with colchicine (50/IM), an inhibitor of gate that possibility, anti-CD14-antibody (mAb) was treated 
translocation of granules by the microtubular system, dimin- with PMNs and stimulation with LPS (serum activated) showed 
ished the fMLP induced IL-8R expression by about 95%, indi- 94% inhibition of IL-8 binding with respect to control (Fig. 2). 
caring that the intracellular g anules may be possible source of 
IL-8R. 3.6. Anti-IL-8R antibody 
To ascertain the source, the activity of the marker enzymes Increased binding of IL-8 in fMLP and SA-LPS stimulated 
of the granules of PMNs myeloperoxidase (azurophilic), ly- neutrophils were due to induction of IL-8R expression, can be 
sozyme (specific), alkaline phosphatase (secretory vesicles) 
were carefully measured in the cultured supernatants after 1.6 5.7 
fMLP treatment. The alkaline phosphatase activity of the su- -,-IL-8binding. 
-0- Alkaline phosphotose. 
pernatant was found to increase with fMLP concentration used -O-Alkaline phospha- & 
tase (Colchicine ,,"~ and correlated with the increase in IL-8 binding (Fig. l). Treat- treated). , / / '~  
-0- IL-8bJnaino ,, / .~ 5.4 ~o ment with colchicine and subsequent s imulation with fMLR 12 (Colchicine , /  / \ - -  
t~eated~. , / /  ,N,, reduced both the binding of IL-8 to PMNs and the alkaline ~ ,-[¢ . 
phosphatase l vel in the cultured supernatant (Fig. 1). The ~ V "~ 'x~ 
levels of myeloperoxidase and lysozyme in the cultured super- ~ I~-"-"" ~ ' \~" '~ 5.1 2; 
natant were not altered by fMLP. We did not directly measure ~ O.E 51, a_ 
the level of gelatinase, a marker enzyme for gelatinase granules. ~ , o 
It has been reported that fMLP at doses of 0.01-1 pM increased ~ ", 3.8 
the release of gelatinase by 25-30%. But we have studied the ~" " ' ,  o 
laJ ~x r'~ CO 
effect of A23187, a calcium ionophore, which at the doses of ~ "i, ,, 
0.3/IM and 1 pM were reported to induce release ofgelatinase 0.4 ~ ~  "4.5 -- 
by 25% and 74%, respectively [19]. Under identical condition ~ 
could not find any increased IL-8 binding on the surface of ~ we 
neutrophil over the control evel (data not presented). ~ 4.2 
O.C ~,l L i 
3.3. Effect of LPS id8 10-7 IG6 10-5 (54 
FM LP conc. (M) 
The effect of bacterial LPS on IL-8R expression, was studied 
by incubating PMNs with 1 ng to 1 ¢tg/ml LPS for 30 min at Fig. 1. Effect of various doses of fMLP on the binding [125I]IL-8 to 
37°C. Only 10 18% IL-8 binding was increased with respect to neutrophils and release of alkaline phosphatase. Human neutrophils 
(2 X 6 10 cells/200 pl) suspended in D-PBS containing 1 mg/ml BSA were 
control (Fig. 2). preincubated with and without colchicine (50 pM) at 37°C for 30 min. 
Then the LPS was incubated with autologous serum for 1 h Then various amounts of fMLP as indicated in the figure were added 
at 37°C. With this LPS the PMNs were incubated for 30 min to the incubation mixture and the incubation was continued for 30 min 
at 37°C, and the binding of IL-8 to PMNs was increased by at 37°C. After incubation the cells were suspended in binding medium 
(RPMI-1640 containing 10 mg/ml BSA and 20 mM HEPES buffer) and 
115% (P < 0.001) and 94% (P < 0.001) over the control at the incubated at 4°C for 2 h with [125I]IL-8 (4 ng/tube). After washing the 
conc. of 10 ng and 100 ng/ml serum activated LPS (SA-LPS), radiolabelled IL-8 bound to neutrophils was measured in a gamma 
respectively. In the subsequent experiments, 10 ng/ml SA-LPS, counter. The results hown are the mean cpm + S.D. of duplicate meas- 
which was the optimum dose for the maximum binding of IL-8 urements. For the assay of alkaline phosphatase, 25/A of the superna- 
was used (Fig. 2). tant was taken from the incubation mixture of the above xperiment 
and mixed with 50 pl of 1.0 M ethanolamine, pH 9.8, containing 
0.5 mM MgC12, 15 mMp-nitrophenyl phosphate and incubated at37°C 
3.4. Source of IL-8R for 30 min and the absorbance measured at405 nm. The results plotted 
Actinomycin D and cycloheximide, the metabolic blockers, are the mean _+ S.D. of triplicate assay. 
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23,000, 39,000 and 47,000 per neutrophil and the Ka values for 
-~ these receptors were 2.7 nM, 3.4 nM and 3.7 nM, respectively 
• ~ - (Fig. 4). 
E ~ 3.8. Affinity crosslinking 2o 
120 ~ - In order to demonstrate he increased number of IL-8R on 
~ PMN surface, the chemical crosslinking of IL-8 to the receptor 
n .~ 
o~ .a  ~ was carried out at 4°C by a bifunctional crosslinking agent, 
~ DSS, in unstimulated, fMLP and SA-LPS stimulated PMNs. 
z //// A Fig. 5 presents the autoradiogram obtained after SDS-PAGE 
Q~ 
a_ 9 0 //// - - analysis under educing condition of the proteins extracted with 
o ~ E o> the detergent (CHAPS; 9 mM) from the crosslinked cells. Com- 
e0 o~ E ~" ,. ~ pared to control, the intensity of the radioactive band at 67 kDa 
_-~ ~_ o_ ~ E was increased in the fMLP and SA-LPS stimulated cells. The 
E~ O_ = 
~-- -~ ~ ÷~ ~ signal from SA-LPS stimulated PMNs was significantly re- 
6 0 c~ ~ ~ ~ ~ duced in the presence of excess unlabelled IL-8 (Fig. 5, lane 4). 
=- ~ 4.  D iscuss ion  
r- 0 "~ ~ .~- E < 
-x~ ~- ~ ~ ,,~,~,= ~-_ In this communication, we have presented evidences in sup- 
._c 30  ~m -~,~ ocn ~° port of bacterial products - formyl  peptide and lipopolysac- 
- -  ....I . - -  ~o O ~,  : ~ , charide mediated upregulation of IL-8 receptor on the surface 
o '~ E - ~ ~ ~ ~_~ E <.~ < of human neutrophils. The formyl peptide has been reported 
~ to activate PMNs through a specific cell surface receptor and 
0 ~ ~ triggers the inflammatory response [14]. The fMLP induced 
Fig. 2. Effect of metabolic nhibitors and anti-CD 14 antibody on bind- 
ing of IL-8 to the LPS (serum activated) stimulated neutrophils. Human 
neutrophils (2 x 10 6 cells/200 #1) suspended RPMI-1640 containing 10 
mg/ml BSA and 20 mM HEPES buffer, pH 7.2, were incubated 37°C ~ 
in three sets of tubes. In one set of tubes anti-CD 14 antibody (4/~1) was 
added to the cells and incubated for 15 min. Another two sets were E 
incubated separately with cycloheximide (10 ~g/ml) and actinomycin D ~ o 
(1/~M) for 30 min under the same conditions. Serum activated LPS (10 
ng/ml) was added to all the tubes and incubated at 37°C for 30 min. I0 ~ a. 
Three controls were run simultaneously in presence of no LPS, 10 ng/ml ~O "~ 
serum free LPS and 10 ng/ml SA-LPS but without he antibody or the m" 
drugs. After incubation, the cells were washed with fresh medium, O ~- 
- -  . .A  cooled and binding were examined using 4 ng IL-8/tube. The figure × 8 ~ "~ 
presents percentage increase in binding of [~I]IL-8 to the surface of E u_ 7////% 
PMNs + S.D. 
¢-  
O 
verified by estimating the level of IL-8 receptor protein on the ~ -6 
cell surface. For this purpose, we incubated unstimulated ~ 
PMNs and as well as fMLP and SA-LPS stimulated PMNs with o ~ ',~¢;'-", 
anti-IL-8R antibody. After washing the first antibody, we incu- -o 4 Y ~/~ 
bated the cells with ~2SI-labelled second antibody (anti-rabbit == U,,"2', 
IgG) for 1 h at 37°C. Then the total binding of IgG was o 7/////~ 
determined in PMNs. As was to be expected, the binding of IgG 
in fMLP and LPS stimulated neutrophils were increased by o 2 
75% (P < 0.001) and 121% (P < 0.001), respectively, over the "E 
,HH. , ,  
unstimulated cells (Fig. 3). Addition of second antibody to the ,,~,, 
fMLP and SA-LPS stimulated cells showed no increase in bind- ' ...... / I / / / / /  
ing of the labelled IgG with respect o control (data not pre- 
sented). Fig. 3. Effect of anti-IL-8 receptor antibody on the fMLP and SA-LPS 
stimulated neutrophil. Human neutrophils (2 × 10 6 cells/200/~1) were 
suspended in RPMI-1640 containing 10 mg/ml BSA and HEPES buffer, 
3.7. Scatchard analysis pH 7.2. In each tube anti-IL-8 receptor antibody (1:100 diluted) was 
The Scatchard analysis was carried out in unstimulated, added and incubated at 37°C for 45 min. The cells were washed, sus- 
fMLP and SA-LPS stimulated PMNs with saturable amounts pended in RPMI-1640 and finally incubated with 125I-labelled anti- 
of IL-8 at 4°C. The Scatchard plot indicates that all the recep- rabbit IgG at 37°C for 1 h. The binding of second antibody was 
measured in a gamma-counter. The figure demonstrates the specific 
tors belong to single class (Fig. 4). The receptor numbers for binding of ['zsI]IgG to the unstimulated, fMLP and SA-LPS stimulated 
unstimulated, fMLP and SA-LPS stimulated PMNs were PMNs in cpm + S.D. in duplicate samples. 
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20.0 ~ Control ~ PMNs. As the LPS induced expression of IL-8R was very low, 
--o- FMLP / - it seems that serum-free LPS is not a potent stimulant for IL-8R 
~" - - e - - ~  expression from PMNs (Fig. 2). 
~ The induction of receptor expression during SA-LPS stimu- x 
E 15.0- lation: (a) could not be blocked by colchicine, but was com- 
£Z 
pletely blocked by actinomycin D or cycloheximide; (b) the 
z level of alkaline phosphatase in the cultured supernatant was 
:; also not increased. This suggests that unlike fMLP and unacti- a_ 
I 0 .0  vated LPS (serum-free), the source of the induced receptor 
-~ during treatment of SA-LPS is de novo protein synthesis. Re- 
c o.~ cently, SA-LPS has been shown to induce de novo protein 
0 0.12 o 
x~ o,o synthesis rapidly [22]. It has been demonstrated that 5-10 min 
co 2J 5.0 ~o.o~ of exposure with SA-LPS was sufficient to release TNFc~ from 
_ ~o6 ' monocytes where de novo protein synthesis was the source of 
~ °o~ I , ,'~., • :"->., _,'~ , TNFc~ [22]. In our case, during SA-LPS stimulation i PMNs, 
• 2o ~oo.~.mo,.j'° 60 80 ,oo 30 min seems to be sufficient o trigger induction of IL-8R 
0.0  , I , J ~ J , I expression through protein synthesis (Fig. 2). 
2 4 6 8 
Count odded (cpm x 10 5) A lipopolysaccharide binding protein (LBP; mol. wt. 55 kDa) 
is constitutively present in the plasma or serum which binds 
Fig. 4. Scatchard analysis of control, fMLP and SA-LPS stimulated LPS to form a LPS-LBP complex [23]. This complex seems to 
neutrophils. Neutrophils, uspended in binding medium were incubated 
with fMLP (104 M) and SA-LPS (10 ng/ml) at 37°C for 30 min. Then be the active species which induces upregulation of IL-8R. 
the cells were incubated at 4°C for 2 h with various amounts of Polymixin-B, an antibiotic which interacts with lipid A moiety 
[lZSI]IL-8 as indicated in the Fig. 4. Another set, without LPS was run of LPS and neutralises the effect of LPS by forming a non 
in parallel. To determine specific binding, the non-specific bindings pyrogenic omplex [24]. This can explain the inability of LPS 
(obtained from experiments done in presence of 100-fold excess co ld  activated with serum in presence of polymixin-B to induce 
IL-8) was subtracted. The result shown is representative of three inde- 
pendent experiments. (e)Neutrophils (control); (IZ) neutrophils (fMLP IL-8R expression. 
stimulated); (, ) neutrophils (SA-LPS stimulated). The surface antigen CD14 is known to be an opsonic recep- 
tor for LBP when it is in complex form with LPS [25]. This 
complex presumably activates the neutrophil through CD14 
upregulation fIL-8R seems to be another such response which and induces expression of IL-8R. Addition of anti-CD14 anti- 
stimulates the neutrophils for augmentation f that response, body may block the binding site for LBP-LPS complex prevent- 
Colchicine is known to block polymerization f tubulin sub- ing the induction of IL-8R expression (Fig. 2). 
units into microtubule and in many cases it is used as a degran- During fMLP and SA-LPS stimulation, ew receptor protein 
ulation blocking agent [20]. The strong inhibitory effect of col- appeared on the surface of PMNs which could be detected by 
chicine on the expression of IL-8 receptor indicates that the antML-8R antibody (Fig. 3). From Scatchard analysis, the 
granules of PMNs are the possible source of IL-8R during receptor numbers in fMLP and SA-LPS stimulated neutrophils 
fMLP stimulation. 
Since the marker enzyme levels for azurophilic and specific I 2 5 4 k D o 
granules were not considerably increased in the supernatant 
and A23187 could not increase the binding of IL-8 to cells, the 
possibility of azurophilic, specific and gelatinase granules being - 9 4 
the source of IL-8R could be excluded. The sharp rise of alka- 
line phosphatase level, the marker enzyme of secretory vesicles ~:' 
of PMNs with concomitant increase in IL-8 binding at the same O - 67  
conc of fMLP, indicates that both the enzyme and the receptor 
may originate from the same compartment of the granules of - 45  
neutrophil (Fig. 1). It is possible that, upon stimulation with 
fMLP, the secretory vesicles are mobilised and fused with the -- 2 9 
plasma membrane. Subsequently, the presynthesized stored re- ~ 2 3 
ceptors of the vesicles expressed on the cell surface and alkaline 
phosphatase, which is reported to be located on the luminal side -- 14.4  
of the vesicles is released [21]. As colchicine blocks the mobili- 
zation of granules containing the receptor and the enzyme, we 
obtained reduced IL-8 binding and alkaline phosphatase r - ~ 
lease when PMNs were treated with colchicine prior to stimula- 
tion with fMLP. Fig. 5. Autoradiograph of IL-8 receptor chemically crosslinked to 
Since metabolic blockers were ineffective in blocking the [125I]IL-8 from human neutrophils analysed by SDS-PAGE (10%). 
increase in IL-8 binding and colchicine could inhibit both IL-8 Lanes 1, 2 and 3 represent control, SA-LPS (10 ng/ml) stimulated and 
fMLP (10 -6 M) stimulated neutrophils. Lane 4 indicates that binding 
binding and enzyme release, it can be suggested that like fMLP, of [~25I]IL-8 to neutrophils inpresence of50-fold excess cold IL-8. The 
serum free LPS induces expression of IL-8R and alkaline phos- positions of molecular weight marker proteins are indicated in the 
phatase release from the secretory vesicle compartments of figure. The result is representative of three independent experiments. 
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were foundtobeconsiderablyhigherthaninunst imulatedcel ls .  [2] Oppenheim, J.J., Zachariae, C.O.C., Mukaida, N. and Mat- 
But the Ka values for unstimulated and stimulated neutrophils sushima, K. (1991) Annu. Rev. Immunol. 9, 617 648. 
remained within the normal range as reported earlier by us [12]. [3] Baggiolini, M. and Clark-Lewis, I. (1992) FEBS Lett. 307, 97- 
101. 
From the autoradiogram, it was observed that the signal for [4] Baggiolini, M., Dewald, B. and Moser, B. (1994) Adv. Immunol. 
radioactivity for stimulated cells appeared at 67 kDa. Polyclo- 55, 97-179. 
nal antibody against 58 kDa protein could inhibit 60 70% bind- [5] Samanta, A.K., Oppenheim, J.J. and Matsushima, K. (1989) 
ing of IL-8 to the cells. Although blocking the receptors with J. Exp. Med. 169, 1185-1189. 
monoclonal antibody against A and B type of receptors can [6] Basemer, J., Hujber, A. and Kuhn, B. (1989) J. Biol. Chem. 264, 
17409-17415. 
specifically answer this question, from the preliminary study we [7] Holmes, W.E., Lee, J., Kuang, W.J., Rice, G.C. and Wood, W.I. 
cannot conclude what type of IL-8R (A or/and B) is expressed (1991) Science 265, 183-189. 
by fMLP and SA-LPS. The bands for fMLP and Sa-LPS stim- [8] Lee, J., Horuk, R., Rice, G.C., Bennett, G.L., Camerato, T. and 
Wood, W.I. (1992) J. Biol. Chem. 267, 16283 16287. 
ulated PMNs showed more than two-fold increase in intensity [9] Samanta, A.K., Oppenheim, J.J. and Matsushima, K. (1990) 
with respect o control which was inconsistent with the binding J. Biol. Chem. 267, 16283-16287. 
data (Fig. 5). The exact reason for this intense band is not [10] Dohlman, H.C., Thorner, J., Caron, M.G. and Lefkowitz, R.J. 
clearly understood. Disappearance of the band in presence of (1991) Annu. Rev. Biochem. 60, 653-688. 
excess unlabelled IL-8 suggests that IL-8 binds to its specific [11] Hebert, C.A., Chuntharapai, A., Smith, M., Colby, T., Kim, J. and 
Horuk, R. (1993) J. Biol. Chem. 268, 18549 18553. 
binding protein which was expressed by SA-LPS (Fig. 5). [12] Samanta, A.K., Dutta, S., Ali, E. (1993) J. Biol. Chem. 268, 6147 
All the evidence presented indicates that both fMLP and 6153. 
SA-LPS upregulate IL-8R on the surface of PMN. It can be [13] Dutta, S., Ali, E. and Samanta, A.K. (1993) FEBS Lett. 325, 
presumed that since neutrophils provide a first line defence 262 266. 
against bacterial infection, these bacterial products signal the [14] Paintner, R.G., Jesaitis, A.J. and Sklar, L.A. (1982) Leukocyte 
chemotaxis inCell Membranes Methods and Reviews (Elliot Elson 
presence of the invading organisms and stimulate PMNs by et al. eds.) Plenum Press, New York. 
rapid alteration of the composition of cell surface proteins. [15] Berry, L.J. (1985) Cellular Biology of Endotoxin in the Hand Book 
Rapid expression of IL-8R is one such response which may help of Endotoxin, Elsevier, New York. 
in the activation of the neutrophils by facilitating the functions [16] Clark, R.A. and Klebanoff, S.J. (1979) J. Immunol. 122, 
2605. of IL-8 for killing the microorganisms at the site of infection [17] Grob, P.M., David, E., Warren, T.C., Deleon, R.P., Farina, P.R. 
from where the fMLP and LPS are generated, and Homon, C.A. (1990) J. Biol. Chem. 265, 8311 8316. 
Briefly, we have presented evidence for the first time that the [18] Dower, S.K., Kronheim, S.R., March, C.J., Conlon, P.J., Hoop, 
bacterial products fMLP and LPS (serum activated)upregulate T.P., Gillis, S. and Urdal, D.L. (1985) J. Exp. Med. 762, 501 
515. 
IL-8R receptor expression in human neutrophils which may [19] Dewald, B.. Bretz, U. and Baggiolini, M. (1982) J. Clin. Invest. 70, 
have a potential role in activating the neutrophils during in- 518. 
flammatory response. [20] Malawista, S.E. and Bodel, P.T. (1967) J. Clin. Invest. 46, 
3937. 
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